Guang-Cong Zhang Selected Research

RNA (Ribonucleic Acid)

8/2022	CircTUBD1 Regulates Radiation-induced Liver Fibrosis Response via a circTUBD1/micro-203a-3p/Smad3 Positive Feedback Loop.
1/2020	microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guang-Cong Zhang Research Topics

Disease

16	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 11/2019
15	Neoplasms (Cancer) 01/2024 - 01/2020
2	Neoplasm Metastasis (Metastasis) 11/2023 - 09/2022
1	Hyperthermia 10/2023
1	Esophageal Squamous Cell Carcinoma 01/2023
1	Fibrosis (Cirrhosis) 08/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 08/2022
1	Necrosis 08/2022
1	Starvation 01/2021
1	Hemolysis 11/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020

Drug/Important Bio-Agent (IBA)

6	Sorafenib (BAY 43-9006)FDA Link 09/2022 - 04/2020
3	Therapeutic UsesIBA 09/2022 - 04/2020
3	Phosphotransferases (Kinase)IBA 08/2022 - 04/2020
3	Cyclin D1IBA 03/2022 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2020
2	IronIBA 11/2023 - 01/2021
2	Transferrin Receptors (Transferrin Receptor)IBA 11/2023 - 01/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2023 - 08/2022
2	RNA Precursors (Precursor, mRNA)IBA 01/2023 - 03/2022
2	RNA (Ribonucleic Acid)IBA 08/2022 - 01/2020
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2020
1	Aldehyde DehydrogenaseIBA 01/2024
1	protein kinase C zetaIBA 01/2024
1	Carcinoembryonic AntigenIBA 11/2023
1	Messenger RNA (mRNA)IBA 11/2023
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 11/2023
1	PolymersIBA 10/2023
1	protoporphyrin IXIBA 10/2023
1	ProdrugsIBA 10/2023
1	erastinIBA 10/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	ChromatinIBA 08/2022
1	LuciferasesIBA 08/2022
1	Collagen Type I (Type I Collagen)IBA 08/2022
1	Collagen Type III (Type III Collagen)IBA 08/2022
1	Connective Tissue Growth FactorIBA 08/2022
1	IridiumIBA 08/2022
1	Photosensitizing Agents (Photosensitizers)IBA 08/2022
1	Nalidixic Acid FDA Link 01/2022
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022
1	Fetal Proteins (Fetoprotein)IBA 01/2022
1	Iohexol (Omnipaque)FDA Link 11/2020
1	BismuthIBA 11/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 05/2020
1	Sirolimus (Rapamycin)FDA Link 05/2020
1	Mechanistic Target of Rapamycin Complex 2IBA 05/2020
1	Zn(II)-phthalocyanine (zinc phthalocyanine)IBA 04/2020
1	NanocapsulesIBA 04/2020
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2020
1	CalciumIBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	Ubiquitin-Conjugating EnzymesIBA 01/2020
1	CateninsIBA 01/2020
1	Cyclin-Dependent Kinase 4IBA 01/2020
1	Staphylococcal Protein A (Protein A)IBA 01/2020
1	Tyrosine (L-Tyrosine)FDA Link 01/2020
1	Long Noncoding RNAIBA 11/2019

Therapy/Procedure

4	Therapeutics 10/2023 - 04/2020
2	Lasers (Laser) 09/2022 - 08/2022
2	Radiotherapy 08/2022 - 11/2020
2	Photochemotherapy (Photodynamic Therapy) 08/2022 - 04/2020
1	Intravenous Administration 09/2022
1	Chemoradiotherapy 11/2020
1	Drug Therapy (Chemotherapy) 11/2020
1	Intravenous Injections 04/2020
1	Phototherapy (Light Therapy) 04/2020
1	Photothermal Therapy 04/2020